The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Effect of Herpes Simplex Suppression on Incidence of HIV among Women in Tanzania
Open accessAbstract
BACKGROUND: Infection with herpes simplex virus type 2 (HSV-2) is associated with an increased risk of acquiring infection with the human immunodeficiency virus (HIV). This study tested the hypothesis that HSV-2 suppressive therapy reduces the risk of HIV acquisition. METHODS: Female workers at recreational facilities in northwestern Tanzania who were 16 to 35 years of age were interviewed and underwent serologic testing for HIV and HSV-2. We enrolled female workers who were HIV-seronegative and HSV-2-seropositive in a randomized, double-blind, placebo-controlled trial of suppressive treatment with acyclovir (400 mg twice daily). Participants attended mobile clinics every 3 months for a follow-up period of 12 to 30 months, depending on enrollment date. The primary outcome was the incidence of infection with HIV. We used a modified intention-to-treat analysis; data for participants who became pregnant were censored. Adherence to treatment was estimated by a tablet count at each visit. RESULTS: A total of 821 participants were randomly assigned to receive acyclovir (400 participants) or placebo (421 participants); 679 (83%) completed follow-up. Mean follow-up for the acyclovir and placebo groups was 1.52 and 1.62 years, respectively. The incidence of HIV infection was 4.27 per 100 person-years (27 participants in the acyclovir group and 28 in the placebo group), and there was no overall effect of acyclovir on the incidence of HIV (rate ratio for the acyclovir group, 1.08; 95% confidence interval, 0.64 to 1.83). The estimated median adherence was 90%. Genital HSV was detected in a similar proportion of participants in the two study groups at 6, 12, and 24 months. No serious adverse events were attributable to treatment with acyclovir. CONCLUSIONS: These data show no evidence that acyclovir (400 mg twice daily) as HSV suppressive therapy decreases the incidence of infection with HIV. (Current Controlled Trials number, ISRCTN35385041 [controlled-trials.com].).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Self-citationWald, A., & Link, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338231 · Cited by 691
Reduction of HIV-1 RNA Levels with Therapy to Suppress Herpes Simplex Virus
Nagot, N., Ouédraogo, A., Foulongne, V., Konaté, I., Weiss, H. A., Vergne, L., Defer, M.-C., Djagbaré, D., Sanon, A., Andonaba, J.-B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062607 · Cited by 389
Self-citationMbopi‐Kéou, F., Grésenguet, G., Mayaud, P., Weiss, H. A., Gopal, R., Matta, M., Paul, J., Brown, D. W. G., Hayes, R. J., Mabey, D. C. W., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315836 · Cited by 243
Self-citationPerry, C. M., & Faulds, D. (1996) · Drugs · doi:10.2165/00003495-199652050-00009 · Cited by 240
Schacker, T., Zeh, J., Hu, H., Hill, E., & Corey, L. (1998) · The Journal of Infectious Diseases · doi:10.1086/314486 · Cited by 236
Asymptomatic Reactivation of Herpes Simplex Virus in Women after the First Episode of Genital Herpes
Koelle, D. M., Benedetti, J., Langenberg, A., & Corey, L. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-6-433 · Cited by 207
Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract
Rebbapragada, A., Wachihi, C., Pettengell, C., Sunderji, S., Huibner, S., Jaoko, W., Ball, B., Fowke, K., Mazzulli, T., Plummer, F. A., et al. (2007) · AIDS · doi:10.1097/qad.0b013e328012b896 · Cited by 186
Zuckerman, R. A., Lucchetti, A., Whittington, W. L. H., Sánchez, J., Coombs, R. W., Zuñiga, R., Magaret, A. S., Wald, A., Corey, L., & Celum, C. (2007) · The Journal of Infectious Diseases · doi:10.1086/522523 · Cited by 185
Clinical Reactivation of Genital Herpes Simplex Virus Infection Decreases in Frequency over Time
Benedetti, J. K., Zeh, J., & Corey, L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-1-199907060-00004 · Cited by 182
Chen, C. Y., Ballard, R. C., Beck-Sague, C. M., Dangor, Y., Radebe, F., Schmid, S., Weiss, J. B., Tshabalala, V., Fehler, G., Htun, Y., et al. (2000) · Sexually Transmitted Diseases · doi:10.1097/00007435-200001000-00005 · Cited by 179
Antibody to Herpes Simplex Virus Type 2 as a Marker of Sexual Risk Behavior in Rural Tanzania
Obasi, A., Mosha, F., Quigley, M., Sekirassa, Z., Gibbs, T., Munguti, K., Todd, J., Grosskurth, H., Mayaud, P., Changalucha, J., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314555 · Cited by 175
Self-citationValacyclovir and Acyclovir for Suppression of Shedding of Herpes Simplex Virus in the Genital Tract
Gupta, R., Wald, A., Krantz, E., Selke, S., Warren, T., Vargas‐Cortes, M., Miller, G., & Corey, L. (2004) · The Journal of Infectious Diseases · doi:10.1086/424519 · Cited by 175
An Electronic Pillbox for Continuous Monitoring of Medication Adherence
Hayes, T. L., Hunt, J. M., Adami, A., & Kaye, J. A. (2006) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2006.260367 · Cited by 157
Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania
Pujades‐Rodríguez, M., Obasi, A. I. N., Mosha, F., Todd, J., Brown, D., Changalucha, J. M., Mabey, D. C. W., Ross, D. A., Grosskurth, H., & Hayes, R. (2002) · AIDS · doi:10.1097/00002030-200202150-00018 · Cited by 132
Self-citationBaeten, J. M., Strick, L. B., Lucchetti, A., Whittington, W. L. H., Sánchez, J., Coombs, R. W., Magaret, A., Wald, A., Corey, L., & Celum, C. (2008) · The Journal of Infectious Diseases · doi:10.1086/593214 · Cited by 132
Conant, M. A., Schacker, T. W., Murphy, R. L., Gold, J., Crutchfield, L., & Crooks, R. J. (2002) · International Journal of STD & AIDS · doi:10.1258/0956462021924550 · Cited by 116
Riedner, G. (2003) · Sexually Transmitted Infections · doi:10.1136/sti.79.5.382 · Cited by 91
Gwanzura, L., McFarland, W. C., Alexander, D., Burke, R. L., & Katzenstein, D. A. (1998) · The Journal of Infectious Diseases · doi:10.1086/517381 · Cited by 88
Kapiga, S., Sam, N. E., Bang, H., Ni, Q., Ao, T. T.-H., Kiwelu, I., Chiduo, S., Ndibe, U., Seage, G. R., COPLAN, P. M., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/513566 · Cited by 75
Watson‐Jones, D., Weiss, H. A., Rusizoka, M., Baisley, K. J., Mugeye, K., Changalucha, J. M., Everett, D., Balira, R., Knight, L., Ross, D. A., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815b2d9c · Cited by 65
Self-citationSeparation methods for acyclovir and related antiviral compounds
Loregian, A., Gatti, R. D., Palù, G., & Palo, E. F. D. (2001) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(01)00379-6 · Cited by 54
Vriesendorp, R., Cohen, A. F., Kristanto, P., Vrijens, B., Rakesh, P., Anand, B. J., Iwebor, H. U., & Stiekema, J. C. J. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0369-2 · Cited by 47
Fonck, K., Kaul, R., Kimani, J., Keli, F., MacDonald, K. S., Ronald, A., Plummer, F., Kirui, P., Bwayo, J. J., Ngugi, E., et al. (2000) · International Journal of STD & AIDS · doi:10.1258/0956462001915327 · Cited by 43
Cowan, F. M., Pascoe, S. J. S., Barlow, K. L., Langhaug, L. F., Jaffar, S. S., Hargrove, J. W., Robinson, N. J., Latif, A. S., Bassett, M. T., Wilson, D. H., et al. (2006) · AIDS · doi:10.1097/01.aids.0000198086.39831.4a · Cited by 41
Self-citationKapiga, S., Sam, N. E., Shao, J. F., Masenga, E. J., Renjifo, B., Kiwelu, I., Manongi, R. N., Fawzi, W. W., & Essex, M. (2003) · Sexually Transmitted Diseases · doi:10.1097/00007435-200303000-00001 · Cited by 36
Vallely, A. J., Kasindi, S., Hambleton, I. R., Knight, L., Chirwa, T. F., Balira, R., Changalucha, J. M., Watson‐Jones, D., Everett, D., Gavyole, A., et al. (2007) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e3180325120 · Cited by 32
Self-citation
Cited by
Attia, S., Egger, M., Müller, M., Zwahlen, M., & Low, N. (2009) · AIDS · doi:10.1097/qad.0b013e32832b7dca · Cited by 1,001
Behavioural strategies to reduce HIV transmission: how to make them work better
Coates, T. J., Richter, L., & Caceres, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60886-7 · Cited by 760
Targeting early infection to prevent HIV-1 mucosal transmission
Haase, A. T. (2010) · Nature · doi:10.1038/nature08757 · Cited by 593
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
Looker, K. J., Magaret, A. S., Turner, K. M. E., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0114989 · Cited by 519
Male circumcision for the prevention of HSV-2 and HPV infections and syphilis.
Tobian, A. A. R., Serwadda, D., Quinn, T. C., Kigozi, G., Gravitt, P. E., Laeyendecker, O., Charvat, B., Ssempijja, V., Riedesel, M., Oliver, A. E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802556 · Cited by 512
Metadata
- Authors
- Watson-Jones, D., Weiss, H. A., Rusizoka, M., Changalucha, J., Baisley, K., Mugeye, K., Tanton, C., Ross, D., Everett, D., Clayton, T., Balira, R., Knight, L., Hambleton, I., Le Goff, J., Belec, L., & Hayes, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-04-10
- Volume
- 358
- Issue
- 15
- Pages
- 1560-1571
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2114967009
- Cited by
- 371
- References
- 27
- FWCI
- 47.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.